Published in World J Gastroenterol on July 28, 2014
Enhancing our understanding of current therapies for hepatitis C virus (HCV). Curr HIV/AIDS Rep (2015) 0.94
Update on hepatitis B and C virus diagnosis. World J Virol (2015) 0.85
Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients. Int J Med Sci (2015) 0.83
HIV and HCV Medications in End-Stage Renal Disease. Semin Dial (2015) 0.82
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol (2016) 0.81
Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol (2016) 0.80
Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysis. PLoS One (2015) 0.77
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature. Risk Manag Healthc Policy (2015) 0.76
Natural killer cells in hepatitis C: Current progress. World J Gastroenterol (2016) 0.76
Toll-Like Receptor 3 is Associated With the Risk of HCV Infection and HBV-Related Diseases. Medicine (Baltimore) (2016) 0.76
Tumour virus epidemiology. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives. Clinicoecon Outcomes Res (2016) 0.75
The dollars and sense of chronic hepatitis C infection management. Can J Infect Dis Med Microbiol (2015) 0.75
Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response. World J Gastroenterol (2015) 0.75
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy. PLoS One (2017) 0.75
A major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report. Infect Agent Cancer (2015) 0.75
Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus. BMC Infect Dis (2017) 0.75
Living donor liver transplantation in Taiwan-challenges beyond surgery. Hepatobiliary Surg Nutr (2016) 0.75
Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum. J Clin Microbiol (2016) 0.75
Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther (2017) 0.75
Epidemiology of hepatitis C in Greece. World J Gastroenterol (2016) 0.75
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis. Clin Drug Investig (2017) 0.75
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Hepatitis C virus infection. N Engl J Med (2001) 18.67
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63
Global epidemiology of hepatitis C virus infection. Lancet Infect Dis (2005) 16.44
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03
Diagnosis, management, and treatment of hepatitis C. Hepatology (2004) 11.62
Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol (2005) 9.00
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med (1999) 6.50
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat (1999) 6.42
Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med (1995) 5.55
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet (1993) 4.51
Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol (1999) 4.48
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology (2004) 4.16
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis (2012) 3.22
Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis (2002) 3.19
Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology (2014) 3.04
Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology (2010) 3.00
Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ (1999) 2.97
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study. J Hepatol (2005) 2.83
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology (2008) 2.46
Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology (2001) 2.19
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Blood banking in China. Lancet (2002) 2.10
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology (2007) 1.98
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Hepatitis C: an epidemiological review. J Viral Hepat (2002) 1.88
Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology (2003) 1.85
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke (2010) 1.82
Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion (2008) 1.81
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology (2008) 1.81
Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. J Infect Dis (2007) 1.70
Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology (2009) 1.66
Hepatitis C virus load and survival among injection drug users in the United States. Hepatology (2005) 1.66
Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol (2003) 1.63
Viral heterogeneity of the hepatitis C virus. J Hepatol (1999) 1.62
Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol (2001) 1.55
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol (2004) 1.55
Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol (2005) 1.48
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol (2010) 1.36
Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology (1997) 1.24
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut (1998) 1.20
The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology (1996) 1.19
Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol (2003) 1.19
Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol (1999) 1.18
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol (2005) 1.17
Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology (2007) 1.16
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat (1999) 1.16
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology (1996) 1.12
Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology (1994) 1.11
Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res (2000) 1.10
Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med (2000) 1.08
Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology (1999) 1.07
Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat (2002) 1.01
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol (2001) 0.99
Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol (2000) 0.96
Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. Gut (2010) 0.95
Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan. Int J Cancer (2006) 0.94
Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis. Hepatology (2012) 0.92
Low HCV replication levels in end-stage hepatitis C virus-related liver disease. J Hepatol (1999) 0.91
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat (2001) 0.88
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer (2004) 0.87
Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut (2004) 0.87
Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol (2002) 0.85
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer (2014) 0.85
Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Trop Med Int Health (2008) 0.82
Multilevel modeling of intra-household spread of hepatitis C virus infection, Karachi, Pakistan. Am J Trop Med Hyg (2007) 0.79
Prevalence of hepatitis C infection in pregnant women in South Australia. Med J Aust (1997) 0.78